Insufficient scRNA-seq data for expression of WFIKKN2 at single-cell level.
Insufficient scRNA-seq data for expression of WFIKKN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 19563.72 | 180 / 180 | 14% | 0.55 | 60 / 430 |
adrenal gland | 100% | 180.85 | 258 / 258 | 10% | 0.67 | 23 / 230 |
brain | 90% | 113.13 | 2365 / 2642 | 20% | 1.47 | 144 / 705 |
prostate | 87% | 60.27 | 212 / 245 | 4% | 0.06 | 21 / 502 |
muscle | 82% | 74.98 | 658 / 803 | 0% | 0 | 0 / 0 |
uterus | 66% | 94.57 | 112 / 170 | 12% | 1.39 | 53 / 459 |
intestine | 74% | 91.86 | 712 / 966 | 1% | 0.03 | 4 / 527 |
heart | 66% | 47.57 | 568 / 861 | 0% | 0 | 0 / 0 |
skin | 63% | 53.36 | 1135 / 1809 | 1% | 0.02 | 3 / 472 |
esophagus | 58% | 42.78 | 834 / 1445 | 1% | 0.03 | 1 / 183 |
blood vessel | 43% | 17.13 | 572 / 1335 | 0% | 0 | 0 / 0 |
stomach | 38% | 31.82 | 138 / 359 | 1% | 0.05 | 2 / 286 |
lung | 33% | 19.03 | 193 / 578 | 2% | 0.04 | 23 / 1155 |
breast | 29% | 10.89 | 135 / 459 | 1% | 0.08 | 14 / 1118 |
thymus | 20% | 7.20 | 131 / 653 | 7% | 0.41 | 42 / 605 |
pancreas | 26% | 8.25 | 85 / 328 | 0% | 0 | 0 / 178 |
bladder | 24% | 8.52 | 5 / 21 | 1% | 0.03 | 6 / 504 |
kidney | 17% | 5.49 | 15 / 89 | 2% | 0.05 | 16 / 901 |
adipose | 19% | 6.54 | 224 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 16% | 0.70 | 13 / 80 |
spleen | 14% | 3.83 | 34 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 1.01 | 25 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0.10 | 1 / 226 | 1% | 0.09 | 5 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001501 | Biological process | skeletal system development |
GO_0060021 | Biological process | roof of mouth development |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0055001 | Biological process | muscle cell development |
GO_0005615 | Cellular component | extracellular space |
GO_0048019 | Molecular function | receptor antagonist activity |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | WFIKKN2 |
Protein name | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 (Growth and differentiation factor-associated serum protein 1) (GASP-1) (hGASP-1) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing-related protein) (WFIKKN-related protein) |
Synonyms | GASP1 WFIKKNRP UNQ9235/PRO31996 |
Description | FUNCTION: Protease-inhibitor that contains multiple distinct protease inhibitor domains. Probably has serine protease- and metalloprotease-inhibitor activity. Inhibits the biological activity of mature myostatin, but not activin (By similarity). . |
Accessions | Q8TEU8 C9J6G4 ENST00000426127.1 ENST00000311378.5 |